Hjem › Prostatakreft › California › Irvine
Kliniske studier for Prostatakreft i Irvine, CA
14 studier for Prostatakreft søker deltakere på steder i og rundt Irvine (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RekruttererFase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RekruttererFase 2
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekruttererFase 3
- CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120), Irvine
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RekruttererFase 3
- UCLA Hematology/Oncology - Irvine, Irvine
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekruttererFase 3
- City of Hope Lennar Foundation Cancer Center ( Site 0059), Irvine
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
RekruttererFase 1
- Hoag Memorial Hospital Presbyterian, Irvine
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruttererFase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
Rekrutterer
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
Rekrutterer
- City of Hope at Irvine Lennar, Irvine
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
RekruttererFase 3
- Research Site, Irvine
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruttererFase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
- Kaiser Permanente-Irvine, Irvine
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RekruttererFase 2
- City of Hope at Irvine Lennar, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Irvine
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
RekruttererFase 2
- Hoag Memorial Hospital Presbyterian, Irvine
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Irvine
- Ikke-småcellet lungekreft25 studier
- Brystkreft23 studier
- Kreft (alle typer)16 studier
- Metastatisk kreft16 studier
- Lungekreft15 studier
- Multipelt myelom14 studier
- Eggstokkreft12 studier
- Alzheimers sykdom11 studier
- Plateepitelcancer i hode og hals11 studier
- Blærekreft11 studier
- Kolorektal kreft10 studier
- Pankreaskreft10 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.